Clinical Trials Logo

Clinical Trial Summary

Sportlegs is a commercially available dietary/sports supplement. It is manufactured by a local, Colorado-based company: Sport Specifics Inc. Although Sportlegs has been on the market for approximately 20-years, very little empirical research has been completed to determine if Sportlegs improves exercise performance. Sport Specifics Inc. has commissioned Colorado State University to investigate the ergogenic effects of Sportlegs.


Clinical Trial Description

1. Study Significance: Based on published survey data, it is estimated that more than 50% of Americans consume dietary supplements, including sport drinks. In light of widespread use, research that evaluates the claims made by the manufacturers of supplements and sport drinks appears to be relevant to a great number of people. Scientific evaluation of Sportlegs will provide potential customers with an opportunity to make an informed decision as to how they wish to spend their money. 2. Sport Specifics Inc., has had considerable commercial success selling their product, Sportlegs. However, they recognize the potential benefit of being able to support claims pertaining to the efficacy of their product with peer-reviewed scientific data. Noteworthy, they also are aware of the potential risks of a scientific evaluation that may demonstrate that their product has no effect on exercise performance, or possibly even a negative/unfavorable effect. 3. Literature Review: To date, only one scientific study of Sportlegs has been published (see attached). The data suggest that Sportlegs may increase blood bicarbonate concentration (an important factor controlling blood pH) and fatigue resistance, as described by time to exhaustion. 4. The primary ingredient in Sportlegs is lactate. Lactate is a modified form of sugar (glucose) and is therefore a potentially important source of fuel for exercise. In this regard, the potential for Sportlegs to improve exercise performance by making more fuel available is intuitively appealing. 5. Historical thinking has misclassified lactic acid as metabolic waste product, and a potential source of fatigue and muscle damage. The modern contemporary opinion is that lactate is a gluconeogenic precursor (i.e. a source of glucose), an excellent source of chemical energy for many organs including the heart and skeletal muscle, and it may even have favorable clinical relevance with respect to a number of chronic diseases (see attached review for more details). The current proposed work may contribute to the field of Exercise Physiology by providing further confirmation of the functional benefits of lactate and correcting previously erroneous interpretations of data. ;


Study Design


Related Conditions & MeSH terms

  • Performance Enhancing Product Use

NCT number NCT06371521
Study type Interventional
Source Colorado State University
Contact Christopher Bell, PhD
Phone (970) 491-7522
Email christopher.bell@colostate.edu
Status Recruiting
Phase Phase 1
Start date January 24, 2024
Completion date June 1, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04203992 - Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes N/A
Enrolling by invitation NCT04474015 - Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment N/A
Completed NCT06112210 - Effect of Hyperbaric Oxygen Therapy N/A
Not yet recruiting NCT05845255 - Validation of the Mjn-SERAS Performance
Completed NCT04230226 - Acute Study on Muscle Soreness, Damage, and Performance N/A
Completed NCT06464120 - Investigating the Post-Activation Performance Enhancement Effects on Skeletal Muscles Under Varied Loading Conditions N/A
Recruiting NCT04290819 - Effect of Creatine and Caffeine on Muscle Performance N/A
Completed NCT05295836 - Effects of Acute Glycerol Ingestion on Performance, Metabolic and Biochemical Markers in International Athletes N/A
Completed NCT04230824 - Chronic Study on Body Composition, Training, Performance, and Recovery N/A
Enrolling by invitation NCT04273776 - A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study Early Phase 1